Best 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor for tyrosinemias
3 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor drugs indicated for tyrosinemias, ranked by our independent rating. The current highest-rated is orfadin. Compare them with all treatments for tyrosinemias or the full 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor class. Not medical advice — always consult a professional.
Top 4-hydroxyphenyl-pyruvate dioxygenase inhibitor for tyrosinemias: 1. Orfadin · 2. Nityr · 3. Harliku
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Orfadin | Not yet rated | Prescription | — | View → |
| 2 | Nityr | Not yet rated | Prescription | — | View → |
| 3 | Harliku | Not yet rated | Prescription | — |
Full ranking · 3 drugs
Frequently asked
- What is the best 4-hydroxyphenyl-pyruvate dioxygenase inhibitor for tyrosinemias?
- By our independent rating, orfadin currently ranks highest among 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor drugs used for tyrosinemias. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which 4-hydroxyphenyl-pyruvate dioxygenase inhibitor drugs treat tyrosinemias?
- pharmaranks lists 3 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor products indicated for tyrosinemias, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.